These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9107569)

  • 1. Sequential activation of alveolar macrophages by IFN-gamma and LPS is required for enhanced growth inhibition of virulent Mycobacterium bovis but not M. bovis BCG.
    Aldwell FE; Wedlock DN; Buddle BM
    Immunol Cell Biol; 1997 Apr; 75(2):161-6. PubMed ID: 9107569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFN-gamma enhances bovine macrophage responsiveness to Mycobacterium bovis: Impact on bacterial replication, cytokine release and macrophage apoptosis.
    Denis M; Wedlock DN; Buddle BM
    Immunol Cell Biol; 2005 Dec; 83(6):643-50. PubMed ID: 16266317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bovine natural killer cells restrict the replication of Mycobacterium bovis in bovine macrophages and enhance IL-12 release by infected macrophages.
    Denis M; Keen DL; Parlane NA; Storset AK; Buddle BM
    Tuberculosis (Edinb); 2007 Jan; 87(1):53-62. PubMed ID: 16730232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro control of Mycobacterium bovis by macrophages.
    Aldwell FE; Wedlock DN; Slobbe LJ; Griffin JF; Buddle BM; Buchan GS
    Tuberculosis (Edinb); 2001; 81(1-2):115-23. PubMed ID: 11463232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-specific lymphocytes enhance nitric oxide production in Mycobacterium bovis BCG-infected bovine macrophages.
    Carpenter E; Fray L; Gormley E
    Immunol Cell Biol; 1998 Aug; 76(4):363-8. PubMed ID: 9723778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron modulates the replication of virulent Mycobacterium bovis in resting and activated bovine and possum macrophages.
    Denis M; Buddle BM
    Vet Immunol Immunopathol; 2005 Sep; 107(3-4):189-99. PubMed ID: 15993492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ability of T cell subsets and their soluble mediators to modulate the replication of Mycobacterium bovis in bovine macrophages.
    Denis M; Wedlock DN; Buddle BM
    Cell Immunol; 2004; 232(1-2):1-8. PubMed ID: 15922710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bovine dendritic cells are more permissive for Mycobacterium bovis replication than macrophages, but release more IL-12 and induce better immune T-cell proliferation.
    Denis M; Buddle BM
    Immunol Cell Biol; 2008 Feb; 86(2):185-91. PubMed ID: 17923848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Mycobacterium bovis BCG infection on regulation of L-arginine uptake and synthesis of reactive nitrogen intermediates in J774.1 murine macrophages.
    Peteroy-Kelly M; Venketaraman V; Connell ND
    Infect Immun; 2001 Sep; 69(9):5823-31. PubMed ID: 11500460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular survival of virulent Mycobacterium bovis and M. bovis BCG in ferret macrophages.
    Cross ML; Aldwell FE; Griffin JF; Mackintosh CG
    Vet Microbiol; 1999 Apr; 66(3):235-43. PubMed ID: 10227125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination of brushtail possums, Trichosurus vulpecula, with Bacille Calmette-Guerin induces T lymphocytes that reduce Mycobacterium bovis replication in alveolar macrophages via a contact-dependent/nitric oxide-independent mechanism.
    Denis M; Wedlock DN; Buddle BM
    Immunol Cell Biol; 2005 Feb; 83(1):57-66. PubMed ID: 15661042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial metabolism, cytokine mRNA transcription and viability of bovine alveolar macrophages infected with Mycobacterium bovis BCG or virulent M. bovis.
    Aldwell FE; Wedlock DN; Buddle BM
    Immunol Cell Biol; 1996 Feb; 74(1):45-51. PubMed ID: 8934653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses induced in cattle by virulent and attenuated Mycobacterium bovis strains: correlation of delayed-type hypersensitivity with ability of strains to grow in macrophages.
    Wedlock DN; Aldwell FE; Collins DM; de Lisle GW; Wilson T; Buddle BM
    Infect Immun; 1999 May; 67(5):2172-7. PubMed ID: 10225871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles for tumor necrosis factor alpha and nitric oxide in resistance of rat alveolar macrophages to Legionella pneumophila.
    Skerrett SJ; Martin TR
    Infect Immun; 1996 Aug; 64(8):3236-43. PubMed ID: 8757859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial lipopolysaccharide-stimulated nitric oxide generation is unrelated to concurrent cytotoxicity of bovine alveolar macrophages.
    Bochsler PN; Mason GL; Olchowy TW; Yang Z
    Inflammation; 1996 Apr; 20(2):177-89. PubMed ID: 8728020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular responses and Mycobacterium bovis BCG growth inhibition by bovine lymphocytes.
    Carpenter E; Fray L; Gormley E
    Immunol Cell Biol; 1997 Dec; 75(6):554-60. PubMed ID: 9492191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide production and mycobacterial growth inhibition by murine alveolar macrophages: the sequence of rIFN-gamma stimulation and Mycobacterium bovis BCG infection determines macrophage activation.
    Hanano R; Kaufmann SH
    Immunol Lett; 1995 Feb; 45(1-2):23-7. PubMed ID: 7622183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early inhibition of mycobacterial growth by human alveolar macrophages is not due to nitric oxide.
    Aston C; Rom WN; Talbot AT; Reibman J
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1943-50. PubMed ID: 9620931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic lipopeptide MALP-2 inhibits intracellular growth of Mycobacterium bovis BCG in alveolar macrophages-preliminary data.
    Jörgens G; Bange FC; Mühlradt PF; Pabst R; Maus UA; Tschernig T
    Inflammation; 2009 Aug; 32(4):247-51. PubMed ID: 19543820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralization of gamma interferon and tumor necrosis factor alpha blocks in vivo synthesis of nitrogen oxides from L-arginine and protection against Francisella tularensis infection in Mycobacterium bovis BCG-treated mice.
    Green SJ; Nacy CA; Schreiber RD; Granger DL; Crawford RM; Meltzer MS; Fortier AH
    Infect Immun; 1993 Feb; 61(2):689-98. PubMed ID: 8423095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.